Join us at the @MySMFM Annual Pregnancy Meeting for an oral presentation highlighting pcfDNA screening with fetal fraction amplification between 8 to 10 weeks, featuring laboratory experience with more than 28,000 samples. This session will share data and insights relevant to

We are live at the @MySMFM Annual Pregnancy Meeting, taking place this week at Caesars Forum in #LasVegas. Our team is connecting with maternal-fetal medicine specialists to discuss advances in prenatal screening and reproductive genetics. Stop by booth # 810 to meet with

We’re looking forward to connecting in #SanDiego at the 10th Liquid Biopsy for Precision Oncology Summit, where Myriad will host a dedicated Engager focused on the next generation of ultrasensitive, tumor-informed MRD testing. 📅 February 3, 2026 | 9:30–11:30 AM PST 📍 San Diego

Today we announced a commercialization roadmap for our Precise MRD™ (molecular residual disease) assay and highlighted compelling data that reinforces the clinical value of ultrasensitive circulating tumor DNA (ctDNA) detection across cancer types. 👉Read more:

Visit #teamMyriad at the 10th Liquid Biopsy for Precision Oncology Summit from February 3 - 5! We look forward to seeing you there. Learn more in the event guide: https://t.co/U9LRR8k7Qo

Today, we announced select unaudited preliminary results for the fourth quarter and full year ended December 31, 2025, and provided full year 2026 financial guidance. 👉Read more: https://t.co/m6NpFgkiSY

Today, we announced that Sam Raha, president and CEO, will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 14 at 5:15 pm PT (8:15 pm ET). See more: https://t.co/AAX7YNDnoZ

2025 was full of wins. Thank you for being part of our journey this year—and letting us be a part of yours! Here’s to an even brighter 2026 ✨💙 #YearInReview #GeneSight #MentalHealthMatters #BetterTogether

Today, we announced we will present new data in eight abstracts at the 2025 San Antonio Breast Cancer Symposium® (SABCS). 👉See more: https://t.co/SZ5B82Kaxz @SABCSSanAntonio

🌟 @Momdotcom recently named SneakPeek® as one of its "11 Must-Haves That Will Make Every Mom's Life Easier"! Our at-home predicted fetal sex test gives you a sneak peek at whether you're expecting a girl or a boy - fast and simple. 👉See more: https://t.co/LqQhnGKE3w

On #InternationalDayofPersonsWithDisabilities, we honor and celebrate the contributions, perspectives, and strengths of people with disabilities. We also recognize the importance of workplaces where every person is included and empowered. We're grateful for our #teamMyriad

🎉Excited to celebrate our own Marie Mount, Senior Director of Marketing at Myriad Genetics, on being named one of Women We Admire's Top 50 Women Leaders of Cincinnati for 2025! As a highly engaged leader, her vision, dedication to excellence, and marketing expertise make a

Clairity, Myriad Genetics, Inc., and MagView announced a joint collaboration in an effort to identify more women at high risk for breast cancer, with the goal of addressing a critical gap in breast cancer risk assessment without creating additional administrative burdens. 👉Read

🎊Myriad Genetics was recently named on @Forbes' list of America's Dream Employers for 2026. This exciting recognition celebrates organizations that stand out for their impact, culture, reputation, and quality of work. We're honored to be included among these companies helping

Thank you to Northwest Newsradio KNWN for talking about the benefits of #genetictesting for Breast Cancer Awareness Month. Grateful to highlight the influential voices of Susan Manley and Rachel Miller Garcia as part of this story. 👉Interview Date: October 30, 2025, 1 PM - 6

On Genetic Counselor Appreciation Day, we honor our incredible team of #geneticcounselors who guide patients and families through their test results and empower them to make informed health decisions. Genetic counselors are vital in bridging science and care by helping others

Today, we announced that Myriad management will participate in two upcoming healthcare conferences. 👉 Read more: https://t.co/eocpIP212x

On #VeteransDay, we honor all who served & sacrificed to protect our freedom. We extend our deepest gratitude to the veterans and veteran family members within Myriad for their courage, dedication, & service. Thank you for your service & lasting contributions to our nation. 💙

Today, we announced MyRisk® Hereditary Cancer Test - the gold standard in germline testing - has been expanded to include genes referenced in the NCCGN Clinical Practical Guidelines in Oncology (NCCN Guidelines®)* and guidelines from American Society of Clinical Oncology (@ASCO).

We're live at #NSGC2025 in Seattle! 🎉 Stop by booth # 317 for: 🍧 Dippin' Dots 📸 Professional headshots 💬 Meaningful conversations about advancing care through #genetictesting Let's connect and explore how Myriad supports #geneticcounselors and their patients - every step of